Roivant Sciences Ltd. Common Shares vs State Street Corporation Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while State Street Corporation Common Stock trades at $175.23 (market cap $47.85B). The key difference: State Street Corporation Common Stock is the larger of the two by market cap, and State Street Corporation Common Stock pays a 2.11% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and State Street Corporation Common Stock for 0 Days on average.
| ROIV | STT | |
|---|---|---|
Market Cap | $25.09B | $47.85B |
Volume | 5,738,571 | 1,607,448 |
Sector | Health | Financials |
52-Week High | $41.81 | $194.26 |
52-Week Low | $16.04 | $111.00 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.36B | $74.39B |
Dividend Yield | — | 2.11% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.
Read more on STT →